In vitro Activity of Monoclonal and Recombinant Yeast Killer Toxin-like Antibodies Against Antibiotic-resistant Gram-positive Cocci

Molecular Medicine

Volumn 6, Issue 7, 2000, Pages 613-619

  Conti, S ^a   Magliani, W ^a   Arseni, S ^a   Dieci, E ^c   Frazzi, R ^a   Salati, A ^a   Varaldo, P E ^b   Polonelli, L ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c NONE

Author keywords

Antibiotic resistant Gram positive Cocci; Haemolyticus; Penicillin resistant Pneumococci; Spleen Lymphocytes; Yeast Killer Toxin

Indexed keywords

ANTIINFECTIVE AGENT; FUNGAL PROTEIN; KILLER FACTOR, YEAST; MONOCLONAL ANTIBODY; MYCOTOXIN;

ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; GRAM POSITIVE COCCI; IMMUNOLOGY; METABOLISM; MOLECULAR MIMICRY; MOUSE; RAT; YEAST;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, MONOCLONAL; DRUG RESISTANCE, MICROBIAL; FUNGAL PROTEINS; GRAM-POSITIVE COCCI; MICE; MOLECULAR MIMICRY; MYCOTOXINS; RATS; YEASTS;

MLCS; MLOWN;

EID: 0034223369     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03401799     Document Type: Article

References (40)

1. C.M. Kunin Resistance to antimicrobial drugs—a worldwide calamity Ann. Int. Med. 1993 118 557 561 10.7326/0003-4819-118-7-199304010-00011 1:STN:280:DyaK3s7ot1yqtA%3D%3D 8442626
2. A. Tomasz Multiple antibiotic-resistant pathogenic bacteria. A report on the Rockfeller University workshop N. Engl. J. Med. 1994 330 1247 1251 10.1056/NEJM199404283301725 1:STN:280:DyaK2c7oslygtQ%3D%3D 8139650
3. H.S. Gold R.C. Moellering Antimicrobial drug-resistance N. Engl. J. Med. 1996 335 1445 1453 10.1056/NEJM199611073351907 1:CAS:528:DyaK28Xnt1SnsLc%3D 8875923
4. M.L. Cohen Epidemiology of drug resistance: implications for a post-antimicrobial era Science 1992 257 1050 1055 10.1126/science.257.5073.1050 1:STN:280:DyaK38zns1Giuw%3D%3D 1509255
5. P.M. Hawkey Action against antibiotic resistance: no time to lose Lancet 1998 351 1298 1299 10.1016/S0140-6736(98)22018-6 1:STN:280:DyaK1czgsF2nsg%3D%3D 9643787
6. B.G. Spratt Antibiotic resistance: counting the cost Curr. Biol. 1996 6 1219 1221 10.1016/S0960-9822(96)00700-2 1:CAS:528:DyaK28XmsVKks7o%3D 8939559
7. J. Biörkman D. Hughes D.I. Andersson Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl. Acad. Sci. U.S.A. 1998 95 3949 3953 10.1073/pnas.95.7.3949
8. L. Polonelli G. Morace Reevaluation of the yeast killer phenomenon J. Clin. Microbiol. 1986 24 866 869 3771773 269048 1:STN:280:DyaL2s%2FjsValsQ%3D%3D
9. L. Polonelli S. Conti M. Gerloni et al. “Antibiobodies”: antibiotic-like anti-idiotypic antibodies J. Med. Vet. Mycol. 1991 29 235 242 10.1080/02681219180000351 1:STN:280:DyaK38%2FksFaitg%3D%3D 1941431
10. L. Polonelli R. Lorenzini F. De Bernardis et al. Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity Scan. J. Immunol. 1993 37 105 110 10.1111/j.1365-3083.1993.tb01671.x 1:CAS:528:DyaK3sXhsVGmt7c%3D
11. L. Polonelli F. De Bernardis S. Conti et al. Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like antiidiotypic antibodies J. Immunol. 1994 152 3175 3182 8144911 1:CAS:528:DyaK2cXis1OltLo%3D
12. L. Polonelli N. Séguy S. Conti et al. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies Clin. Diagn. Lab. Immunol. 1997 4 142 146 9067647 170493 1:CAS:528:DyaK2sXit1aqt7g%3D
13. W. Magliani S. Conti F. De Bernardis et al. Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity Nature Biotechnol. 1997 15 155 158 10.1038/nbt0297-155 1:CAS:528:DyaK2sXptFaqsg%3D%3D
14. W. Magliani S. Conti M. Gerloni D. Bertolotti L. Polonelli Yeast killer systems Clin Microbiol Rev. 1997 10 369 400 9227858 172926 1:CAS:528:DyaK2sXkvFymt7k%3D
15. S. Conti F. Fanti W. Magliani et al. Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies J. Infect. Dis. 1998 177 807 811 10.1086/517815 1:CAS:528:DyaK1cXhsF2ktL0%3D 9498471
16. N. Séguy L. Polonelli E. Dei-Cas J.C. Cailliez Perspectives in the control of Pneumocystis infections by using Pichia anomala killer toxinlike antiidiotypic antibodies FEMS Immunol. Med. Microbiol. 1998 22 145 149 10.1016/S0928-8244(98)00072-8 9792073
17. L. Polonelli F. De Bernardis S. Conti et al. Human natural yeast killer toxin-like candidacidal antibodies J. Immunol. 1996 156 1880 1885 8596040 1:CAS:528:DyaK28Xht1ejurw%3D
18. L. Polonelli G. Morace Production and characterization of yeast killer toxin monoclonal antibodies J. Clin. Microbiol. 1987 25 460 462 2434524 265928 1:CAS:528:DyaL2sXhtVSlsrw%3D
19. W. Magliani L. Polonelli S. Conti et al. Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant antiidiotypes Nature Med. 1998 4 705 709 10.1038/nm0698-705 1:CAS:528:DyaK1cXjsFymsb0%3D 9623980
20. R.C. Moellering Introduction: problems with antimicrobial resistance in gram-positive cocci Clin. Infect. Dis. 1998 26 1177 1178 10.1086/520288 9597248
21. Centers for Disease ControlPrevention. Update: Staphylococcus aureus with reduced susceptibility to vancomycin—United States MMWR 1997 46 813 815
22. K. Hiramatsu N. Aritaka H. Hanaki et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin Lancet 1997 350 1670 1673 10.1016/S0140-6736(97)07324-8 1:CAS:528:DyaK1cXns1em 9400512
23. K. Sieradzki R.B. Roberts S.W. Haber A. Tomasz The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection N. Engl. J. Med. 1999 340 517 523 10.1056/NEJM199902183400704 1:STN:280:DyaK1M7jsVShsw%3D%3D 10021472
24. R.S. Schwalbe J.T. Stapleton P.H. Gilligan Emergence of vancomycin resistance in coagulase-negative staphylococci N. Engl. J. Med. 1987 316 927 931 10.1056/NEJM198704093161507 1:STN:280:DyaL2s7ksVGhsA%3D%3D 3821839
25. L.A. Veach M.A. Pfaller M. Barrett F.P. Koontz R.P. Wenzel Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection J. Clin. Microbiol. 1990 28 2064 2068 2229388 268104 1:CAS:528:DyaK3cXlsVyku7g%3D
26. K. Sieradzki R.B. Roberts D. Serur J. Hargrave A. Tomasz Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin Lancet 1998 351 880 881 10.1016/S0140-6736(05)70291-9 1:STN:280:DyaK1c7osVarsQ%3D%3D 9525371
27. L.W. McMurray D.S. Kernodle N. Barg Characterization of a widespread strain of methicillin-susceptible Staphylococcus aureus associated with nosocomial infections J. Infect. Dis. 1990 162 759 762 10.1093/infdis/162.3.759 1:STN:280:DyaK3czlsVOhtA%3D%3D 2388000
28. B.E. Murray Vancomycin-resistant enterococci Am. J. Med. 1997 102 284 293 10.1016/S0002-9343(99)80270-8 1:STN:280:DyaK2szmtVKgtg%3D%3D 9217598
29. R.C. Moellering Vancomycin-resistant enterococci Clin. Infect. Dis. 1998 26 1196 1199 10.1086/520283 9597252
30. R.C. Moellering The enterococcus: a classic example of the impact of antimicrobial resistance on therapeutic options J. Antimicrob. Chemother. 1991 28 1 12 10.1093/jac/28.1.1 1769929
31. S. Dutka-Malen B. Blaimont G. Wauters P. Courvalin Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus. Antimicrob. Agents Chemother. 1994 38 1675 1677 10.1128/AAC.38.7.1675 1:CAS:528:DyaK2cXksFektbs%3D 7979308
32. G. French Y. Abdulla R. Heathcock S. Poston J. Cameron Vancomycin resistance in south London Lancet 1992 339 818 819 10.1016/0140-6736(92)91954-7 1:STN:280:DyaK387psV2huw%3D%3D 1347850
33. R. Fontana M. Ligozzi C. Pedrotti E.M. Padovani G. Cornaglia Vancomycin-resistant Bacillus circulans carrying the vanA gene responsible for vancomycin resistance in enterococci Eur. J. Clin. Microbiol. Infect. Dis. 1997 16 473 474 10.1007/BF02471915 1:STN:280:DyaK2szpt1Sisw%3D%3D 9248754
34. C. Poyart C. Pierre G. Quesne B. Pron P. Berche P. Trieu-Cuot Emergence of vancomycin resistance in the genus Streptococcus characterization of a vanB transferable determinant in Streptococcus bovis. Antimicrob. Agents Chemother. 1997 41 24 29 8980749 1:CAS:528:DyaK2sXhtlWqsQ%3D%3D
35. A. Tomasz Antibiotic resistance in Streptococcus pneumoniae Clin. Infect. Dis. 1997 24 Suppl.1 S85 88 10.1093/clinids/24.Supplement_1.S85 1:CAS:528:DyaK2sXms1Gjtg%3D%3D 8994784
36. R. Novak B. Henriques E. Charpentier S. Normark E. Tuomanen Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999 399 590 593 10376600 1:CAS:528:DyaK1MXjvFegtLY%3D
37. H.G. Boman Peptide antibiotics and their role in innate immunity Annu. Rev. Immunol. 1995 13 61 92 10.1146/annurev.iy.13.040195.000425 1:CAS:528:DyaK2MXltFamtLc%3D 7612236
38. R.E. Hancock Peptide antibiotics Lancet 1997 349 418 422 10.1016/S0140-6736(97)80051-7 1:CAS:528:DyaK2sXhvVamur0%3D 9033483
39. R.I. Lehrer A.K. Lichtenstein T. Ganz Defensins: antimicrobial and cytotoxic peptides of mammalian cells Annu. Rev. Immunol. 1993 11 105 128 10.1146/annurev.iy.11.040193.000541 1:CAS:528:DyaK3sXktVKmu7w%3D 8476558
40. P. Nicolas A. Mor Peptides as weapons against microorganisms in the chemical defense system of vertebrates Annu. Rev. Microbiol. 1994 49 277 304 10.1146/annurev.mi.49.100195.001425